Together, we are exploring new ways to treat cancer and improve health
One of the most exciting advances in cancer research is the idea that treatment can be very precise, based on the unique genetic information found in each of us. It’s called Precision Medicine and we are at the leading edge.
Instead of one-size-fits-all treatments, we treat individuals based on their unique characteristics.
Thanks to the mapping of the human genome, we can explore options for treating individuals with highly targeted and effective solutions. Considering factors such as health history, lifestyle and diet can dramatically improve outcomes for those with cancer.
Scientists at the University of Calgary are making advances into some of the leading causes of death from cancer.
Our research leverages the potential of precision medicine. Lung, brain, head and neck, blood and pediatric cancers are in our sights.
Together, we will create a future of health where cancer is beaten at every stage.
Research outcomes to benefit society
Fuel transformational change
Individual pathways to treatment
Cancer attacks every person individually, so we are developing ways to treat each individual person.
The more we know about how cancer acts, and how it impacts each patient, the more precise and effective treatment can be.
We’re generating breakthroughs. Genome sequencing is leading to personalized therapies. New tests are identifying faint chemical fingerprints left in the blood by tumours. Researchers are finding ways to kill cancer by giving it a virus.
With precision medicine we are prolonging lives and hitting the hard targets.
Offering hope to patients, now and in the future
Before a treatment is made available for public use, it first goes through rigorous testing to ensure its safety and effectiveness. This testing is also known as a clinical trial.
As director of the Tom Baker Cancer Centre's Clinical Trials Unit, Dr. Gwyn Bebb knows that clinical trials are the reason for improvements in cancer treatments.
More than 100 trials are underway at the Tom Baker Clinical Trials Unit. These studies are providing thousands of patients access to the latest treatment innovations, increasing knowledge and expertise to effectively treat millions of others.